CINECA IRIS Institutional Research Information System

BOCCHIO CHIAVETTO, LUISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.180
EU - Europa 6.487
AS - Asia 1.365
AF - Africa 242
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 16
OC - Oceania 3
Totale 16.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.067
RU - Federazione Russa 3.377
DE - Germania 1.456
CN - Cina 727
UA - Ucraina 608
SG - Singapore 501
SE - Svezia 281
CM - Camerun 236
GB - Regno Unito 226
IT - Italia 140
FI - Finlandia 132
CA - Canada 111
IE - Irlanda 93
FR - Francia 84
TR - Turchia 84
PL - Polonia 66
EU - Europa 22
IN - India 10
IL - Israele 8
IR - Iran 5
PE - Perù 5
VN - Vietnam 5
BR - Brasile 4
HK - Hong Kong 4
HU - Ungheria 4
ID - Indonesia 4
BE - Belgio 3
AM - Armenia 2
AR - Argentina 2
AT - Austria 2
AU - Australia 2
EC - Ecuador 2
ES - Italia 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
MY - Malesia 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
LY - Libia 1
MN - Mongolia 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 16.315
Salva come PNG Salva come JPEG
Città #
Fairfield 1.564
Woodbridge 699
Seattle 694
Ashburn 675
Houston 660
Beijing 636
Cambridge 604
Jacksonville 559
Chandler 539
Wilmington 504
Moscow 304
Ann Arbor 213
Singapore 109
The Dalles 107
Ottawa 106
Boardman 103
Chicago 94
Dublin 90
Lawrence 90
Princeton 86
New York 70
Kraków 65
Helsinki 64
Rome 61
San Diego 49
London 47
Saint Petersburg 35
Yubileyny 25
Portsmouth 24
Nanjing 17
Los Angeles 16
Norwalk 16
Prescot 16
Lauterbourg 14
Cedar Knolls 13
Kunming 13
Redwood City 13
Chiswick 12
Guangzhou 12
Milan 10
Hefei 9
Islington 9
Kilburn 9
Dearborn 8
Falls Church 7
Hounslow 7
Mcallen 7
Düsseldorf 6
Chengdu 5
Nanchang 5
Redmond 5
St Louis 5
Hanoi 4
New Bedfont 4
Shanghai 4
West Jordan 4
Atlanta 3
Brussels 3
Hong Kong 3
Jinan 3
Kocaeli 3
Rimini 3
Segrate 3
Shenyang 3
Sotto 3
Almaty 2
Behshahr 2
Garden City 2
Hanover 2
Istanbul 2
Lake Forest 2
Mexico City 2
Miami Beach 2
Novara 2
Palermo 2
Rio de Janeiro 2
San Francisco 2
Serrata 2
Toronto 2
Wuhan 2
Yerevan 2
Abu Dhabi 1
Acton 1
Ampang 1
Andover 1
Ankara 1
Bandar 1
Bareggio 1
Baronissi 1
Bergamo 1
Brescia 1
Brisbane 1
Bristol 1
Cardiff 1
Changsha 1
Chesapeake 1
Chongqing 1
Council Bluffs 1
Dallas 1
Delta 1
Totale 9.204
Salva come PNG Salva come JPEG
Nome #
The -1727 A/T, -50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms and resistance to antipsychotics in schizophrenia 429
Immune and metabolic alterations in first episode psychosis (FEP) patients 363
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 307
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 274
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients 274
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis 268
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects 268
Allelic variation in the human prodynorphin gene promoter and schizophrenia 251
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients 244
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 243
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 240
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. 236
Effetti biomolecolari del maltrattamento infantile: il ruolo dell'epigenetica e dell'infiammazione 236
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study 233
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease 233
Aspetti biologici e neuropsicologici del maltrattamento e abuso infantili 233
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 231
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid 225
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses 224
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 220
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 217
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia 216
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 216
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs 215
Glucose metabolism alterations in patients with bipolar disorder 214
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence 214
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study 213
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 211
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients 211
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. 209
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 208
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia 207
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 207
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor 206
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 203
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 202
Season of birth and inflammatory response system in schizophrenia 200
Markers of Alzheimer's disease in a population attending a memory clinic 199
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment 199
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients 198
Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study 197
Blood microRNA changes in depressed patients during antidepressant treatment 196
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 196
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 195
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter 193
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 193
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review 192
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 192
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease 189
G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 189
VEGF serum levels in depressed patients during SSRI antidepressant treatment 189
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 188
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 186
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 184
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics 184
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 180
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases 178
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 177
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 174
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects 167
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 154
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 151
Association study of-1727 A/T,-50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms with schizophrenia 147
Gene-environment interaction in major depression: focus on experience-dependent biological systems 142
CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors 141
Association study and meta-analysis of-308 A/G functional polymorphism in TNF alpha gene with schizophrenia 140
Association between IL-1 cluster and IL-10 gene polymorphisms and schizophrenia 139
Association between IL-1 beta-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia 136
Association study between -1727A/T, -50C/T and (CAA)(N) repeat GSK-3beta gene polymorphisms and Bipolar Disorder 135
The cytokine network genes and resistance to antipsychotics in schizophrenia 134
Influence of G1730A polymorphism of estrogen receptor beta gene on brain morphology in postmenopausal women 132
Evidence in Support of the AD Biomarker Dynamic Model from a Memory Clinic Naturalistic Series of Patients with Mild Cognitive Impairment 130
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 129
Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state 124
Serum brain derived neurotrophic factor concentrations in attention deficit hyperactivity disorder (ADHD) 124
Serum and plasma BDNF levels in major depression: Replication study plus meta-analysis 122
Childhood trauma and glucose metabolism in patients with first-episode psychosis 118
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study 111
miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity 111
Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease. 108
Molecular mechanisms of brain stimulation. (Chapter 11). 106
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 91
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 88
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 75
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup. 72
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations 59
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 57
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 51
P.264 Association of single nucleotide polymorphisms in the 3’ untranslated region of SLC1A2 with major depressive disorder and relative endophenotypes 48
Vascular endothelial growth factor (VEGF) serum: putative predictive biomarkers for the electroconvulsive therapy (ECT) in depressed patients 39
Reduction of oxytocin plasma levels in borderline personality disorder and normalization induced by psychotherapies 9
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 5
null 5
null 2
null 1
null 1
null 1
Totale 16.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020966 0 0 0 0 0 0 0 0 0 594 254 118
2020/20212.814 322 294 248 400 288 243 322 142 125 116 247 67
2021/2022598 108 59 128 46 9 21 21 139 33 23 8 3
2022/20231.614 176 11 11 221 167 344 1 230 299 43 87 24
2023/2024558 27 40 62 68 59 86 21 10 0 16 5 164
2024/20253.893 34 22 18 3 113 319 2.282 779 302 21 0 0
Totale 16.474